Policy, Research

Shockwave (SWAV): Volatility Ahead?

John Leppard, VP Senior Healthcare Analyst
09 February 2023


We give no better than 50% odds to CMS forestalling an implied facility cut of 25%+ for Shockwave’s (SWAV) C2 coronary intravascular lithotripsy (IVL) procedures, once its Transitional Pass-Through (TPT) payment ends next year as part of the agency’s CY24 hospital outpatient/ASC proposed rule due out in early July.

Want to learn more? Download the Report.


Public Policy Research
Identify opportunity and risks driven by public policy.
Fundamental Equity Research
Gain a comprehensive view of global themes, industries, and companies.
Forensic Accounting Research
Understand implications of public company financial reporting.